Akero Therapeutics Inc
(AKRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -100,777 | -68,353 | -44,023 | -15,090 | -79,207 |
| Depreciation Amortization | 1,107 | 735 | 324 | 132 | 100 |
| Accounts payable and accrued liabilities | 3,273 | 3,469 | -1,121 | 1,177 | 2,481 |
| Other Working Capital | 9,727 | 7,182 | 419 | -5,802 | 2,085 |
| Other Operating Activity | 6,989 | 3,981 | 6,021 | 1,237 | 3,737 |
| Operating Cash Flow | $-79,681 | $-52,986 | $-38,380 | $-18,346 | $-70,804 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,280 | 30,280 | 8,346 | 19,000 | -9,613 |
| PPE Investments | N/A | N/A | N/A | N/A | -148 |
| Investing Cash Flow | $42,280 | $30,280 | $8,346 | $19,000 | $-9,761 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,123 | 851 | 632 | 24 | 203,055 |
| Other Financing Activity | -521 | -492 | -342 | 0 | 52 |
| Financing Cash Flow | $602 | $359 | $290 | $24 | $203,107 |
| Beginning Cash Position | 187,390 | 187,390 | 187,390 | 187,390 | 64,848 |
| End Cash Position | 150,591 | 165,043 | 157,646 | 188,068 | 187,390 |
| Net Cash Flow | $-36,799 | $-22,347 | $-29,744 | $678 | $122,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,681 | -52,986 | -38,380 | -18,346 | -70,804 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -148 |
| Free Cash Flow | -79,681 | -52,986 | -38,380 | -18,346 | -70,952 |